Characteristics Associated With Differences in Survival Among Black and White Women With Breast Cancer
Jeffrey H. Silber(Children's Hospital of Philadelphia), Kevin R. Fox(Hospital of the University of Pennsylvania), Justin Ludwig(Children's Hospital of Philadelphia), Bijan A. Niknam(Children's Hospital of Philadelphia), Bruce J. Giantonio(Northwestern University), Min Wang(Red Cross Hospital), Wei Wang(First Affiliated Hospital of Wannan Medical College), Paul R. Rosenbaum(Uppsala University), Richard N. Ross(Children's Hospital of Philadelphia), Orit Even‐Shoshan(Children's Hospital of Philadelphia), Yun Teng(Children's Hospital of Philadelphia), Amy S. Clark(Abramson Center for Jewish Life)
Cited by 306
Related Papers
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k
Demographic history and rare allele sharing among human populations
|Proceedings of the National Academy of Sciences|2011|733
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer
|JAMA Oncology|2020|707
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
|Journal of Clinical Oncology|1999|670